The dot blot analysis revealed the simultaneous expression of antibodies against GST-RPLP0, RPLP1, and RPLP2 proteins, detected in 51 out of 100 serum samples from patients with SLE. Here, RPLP2 is linked to systemic lupus erythematosus.